The raise will support Rivermark’s pivotal trial, while allowing the medtech company to ready its FloStent system for ...

An artificial intelligence (AI) system was better at detecting clinically significant prostate cancer on MRI compared with radiologists, a noninferiority, confirmatory study showed. In a subset of 400 ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy ...

Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...

Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell Carcinoma The median follow-up for ...

ProUroCare Medical has announced it has received FDA 510(k) clearance for its ProUroScan prostate mechanical imaging system, according to a news release (pdf). The company describes the ProUroScan as ...

(MENAFN- EIN Presswire) EINPresswire/ -- Memorial becomes first health system in Broward County to use advanced prostate imaging technology The Memorial Healthcare System Division of Urology has begun ...

Exact Imaging reported it has closed on $10 million in financing in a round led by iGan Partners. The Toronto-based company said proceeds will be used to help with sales and adoption of the ExactVu ...

Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minnesota, announced that it has secured market ...